Molecular mechanisms of HPV induced carcinogenesis in head and neck

Oral Oncology

Volumn 50, Issue 5, 2014, Pages 356-363

  Rampias, Theodoros ^a   Sasaki, Clarence ^a   Psyrri, Amanda ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

HPV; Notch; Oropharynx cancer; Tumor suppressor pathways; Wnt

Indexed keywords

GENETICS; HEAD AND NECK TUMOR; HUMAN; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; PATHOGENICITY; VIROLOGY; VIRUS GENOME;

GENOME, VIRAL; HEAD AND NECK NEOPLASMS; HUMANS; PAPILLOMAVIRIDAE;

EID: 84899121619     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.07.011     Document Type: Article

References (99)

1. D.M. Parkin, P. Pisani, and J. Ferlay Estimates of the worldwide incidence of eighteen major cancers in 1985 Int J Cancer J Int Du Cancer 54 1993 594 606
2. A. Jemal, E.P. Simard, C. Dorell, A.M. Noone, L.E. Markowitz, and B. Kohler et al. Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in Human Papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels J Natl Cancer Inst 105 2013 175 201
3. A.K. Chaturvedi, E.A. Engels, R.M. Pfeiffer, B.Y. Hernandez, W. Xiao, and E. Kim et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States J Clinical Oncol: Official J Am Soc Clin Oncol 29 2011 4294 4301
4. T. Rampias, C. Sasaki, P. Weinberger, and A. Psyrri E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells J Natl Cancer Inst 101 2009 412 423
5. F. Dayyani, C.J. Etzel, M. Liu, C.H. Ho, S.M. Lippman, and A.S. Tsao Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC) Head Neck Oncol 2 2010 15
6. N. Stransky, A.M. Egloff, A.D. Tward, A.D. Kostic, K. Cibulskis, and A. Sivachenko et al. The mutational landscape of head and neck squamous cell carcinoma Science 333 2011 1157 1160
7. N. Agrawal, M.J. Frederick, C.R. Pickering, C. Bettegowda, K. Chang, and R.J. Li et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 Science 333 2011 1154 1157
8. L.W. Engel, C.A. Heilman, and P.M. Howley Transcriptional organization of bovine papillomavirus type 1 J Virol 47 1983 516 528
9. I. Ilves, S. Kivi, and M. Ustav Long-term episomal maintenance of bovine papillomavirus type 1 plasmids is determined by attachment to host chromosomes, which Is mediated by the viral E2 protein and its binding sites J Virol 73 1999 4404 4412
10. C.W. Lehman, and M.R. Botchan Segregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation Proc Nat Acad Sci USA 95 1998 4338 4343
11. N. Bastien, and A.A. McBride Interaction of the papillomavirus E2 protein with mitotic chromosomes Virology 270 2000 124 134
12. M.K. Baxter, M.G. McPhillips, K. Ozato, and A.A. McBride The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4 J Virol 79 2005 4806 4818
13. D.R. Brown, D. Kitchin, B. Qadadri, N. Neptune, T. Batteiger, and A. Ermel The human papillomavirus type 11 E1-E4 protein is a transglutaminase 3 substrate and induces abnormalities of the cornified cell envelope Virology 345 2006 290 298
14. R. Wilson, F. Fehrmann, and L.A. Laimins Role of the E1-E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31 J Virol 79 2005 6732 6740
15. W.L. Peh, J.L. Brandsma, N.D. Christensen, N.M. Cladel, X. Wu, and J. Doorbar The viral E4 protein is required for the completion of the cottontail rabbit papillomavirus productive cycle in vivo J Virol 78 2004 2142 2151
16. D. DiMaio, C.C. Lai, and D. Mattoon The platelet-derived growth factor beta receptor as a target of the bovine papillomavirus E5 protein Cytokine Growth Factor Rev 11 2000 283 293
17. L. Petti, L.A. Nilson, and D. DiMaio Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein EMBO J 10 1991 845 855
18. N. Kivi, D. Greco, P. Auvinen, and E. Auvinen Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression Oncogene 27 2008 2532 2541
19. A.J. Klingelhutz, and A. Roman Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses Virology 424 2012 77 98
20. G. Orth Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses Semin Immunol 18 2006 362 374
21. C.B. Woodman, S.I. Collins, and L.S. Young The natural history of cervical HPV infection: unresolved issues Nat Rev Cancer 7 2007 11 22
22. S. Jeon, and P.F. Lambert Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis Proc Nat Acad Sci USA 92 1995 1654 1658
23. T. Giroglou, L. Florin, F. Schafer, R.E. Streeck, and M. Sapp Human papillomavirus infection requires cell surface heparan sulfate J Virol 75 2001 1565 1570
24. J.G. Joyce, J.S. Tung, C.T. Przysiecki, J.C. Cook, E.D. Lehman, and J.A. Sands et al. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes J Biol Chem 274 1999 5810 5822
25. S. Shafti-Keramat, A. Handisurya, E. Kriehuber, G. Meneguzzi, K. Slupetzky, and R. Kirnbauer Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses J Virol 77 2003 13125 13135
26. L. Banks, S.C. Barnett, and T. Crook HPV-16 E7 functions at the G1 to S phase transition in the cell cycle Oncogene 5 1990 833 837
27. S.N. Boyer, D.E. Wazer, and V. Band E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway Cancer Res 56 1996 4620 4624
28. S. Chellappan, V.B. Kraus, B. Kroger, K. Munger, P.M. Howley, and W.C. Phelps et al. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product Proc Nat Acad Sci USA 89 1992 4549 4553
29. N. Dyson, P.M. Howley, K. Munger, and E. Harlow The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product Science 243 1989 934 937
30. S.L. Gonzalez, M. Stremlau, X. He, J.R. Basile, and K. Munger Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7 J Virol 75 2001 7583 7591
31. K. Munger, B.A. Werness, N. Dyson, W.C. Phelps, E. Harlow, and P.M. Howley Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product EMBO J 8 1989 4099 4105
32. K. Huh, X. Zhou, H. Hayakawa, J.Y. Cho, T.A. Libermann, and J. Jin et al. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor J Virol 81 2007 9737 9747
33. J.O. Funk, S. Waga, J.B. Harry, E. Espling, B. Stillman, and D.A. Galloway Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein Genes Dev 11 1997 2090 2100
34. D.L. Jones, R.M. Alani, and K. Munger The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2 Genes Dev 11 1997 2101 2111
35. F. Noya, W.M. Chien, T.R. Broker, and L.T. Chow P21cip1 Degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human papillomavirus E7 J Virol 75 2001 6121 6134
36. M. Tommasino, J.P. Adamczewski, F. Carlotti, C.F. Barth, R. Manetti, and M. Contorni et al. HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A Oncogene 8 1993 195 202
37. A.M. Helt, J.O. Funk, and D.A. Galloway Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells J Virol 76 2002 10559 10568
38. N. Avvakumov, J. Torchia, and J.S. Mymryk Interaction of the HPV E7 proteins with the pCAF acetyltransferase Oncogene 22 2003 3833 3841
39. A. Baldwin, K.W. Huh, and K. Munger Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function J Virol 80 2006 6669 6677
40. D. Holland, K. Hoppe-Seyler, B. Schuller, C. Lohrey, J. Maroldt, and M. Durst et al. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein Cancer Res 68 2008 9964 9972
41. M. Scheffner, B.A. Werness, J.M. Huibregtse, A.J. Levine, and P.M. Howley The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 63 1990 1129 1136
42. X. Li, and P. Coffino High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation J Virol 70 1996 4509 4516
43. Z. Songyang, A.S. Fanning, C. Fu, J. Xu, S.M. Marfatia, and A.H. Chishti et al. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains Science 275 1997 73 77
44. T. Kiyono, A. Hiraiwa, M. Fujita, Y. Hayashi, T. Akiyama, and M. Ishibashi Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein Proc Nat Acad Sci USA 94 1997 11612 11616
45. C. Lee, and L.A. Laimins Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31 J Virol 78 2004 12366 12377
46. D. Gardiol, C. Kuhne, B. Glaunsinger, S.S. Lee, R. Javier, and L. Banks Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation Oncogene 18 1999 5487 5496
47. M.L. Nguyen, M.M. Nguyen, D. Lee, A.E. Griep, and P.F. Lambert The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo J Virol 77 2003 6957 6964
48. S. Roberts, C. Delury, and E. Marsh The PDZ protein discs-large (DLG): the 'Jekyll and Hyde' of the epithelial polarity proteins FEBS J 279 2012 3549 3558
49. F. Facciuto, A.L. Cavatorta, M.B. Valdano, F. Marziali, and D. Gardiol Differential expression of PDZ domain-containing proteins in human diseases - challenging topics and novel issues FEBS J 279 2012 3538 3548
50. K. Zanier, A. Ould M'hamedould Sidi, C. Boulade-Ladame, V. Rybin, A. Chappelle, and A. Atkinson et al. Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53 Structure 20 2012 604 617
51. L. Gewin, and D.A. Galloway E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc J Virol 75 2001 7198 7201
52. T. Veldman, I. Horikawa, J.C. Barrett, and R. Schlegel Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein J Virol 75 2001 4467 4472
53. B.J. Braakhuis, P.J. Snijders, W.J. Keune, C.J. Meijer, H.J. Ruijter-Schippers, and C.R. Leemans et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus J Natl Cancer Inst 96 2004 998 1006
54. S. Shintani, Y. Nakahara, M. Mihara, Y. Ueyama, and T. Matsumura Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas Oral Oncol 37 2001 498 504
55. P.M. Weinberger, Z. Yu, B.G. Haffty, D. Kowalski, M. Harigopal, and J. Brandsma et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis J Clinical Oncol: Official J Am Soc Clinical Oncol 24 2006 736 747
56. R.J. Slebos, Y. Yi, K. Ely, J. Carter, A. Evjen, and X. Zhang et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma Clin Cancer Res: Official J Am Assoc Cancer Res 12 2006 701 709
57. N.F. Schlecht, R.D. Burk, L. Adrien, A. Dunne, N. Kawachi, and C. Sarta et al. Gene expression profiles in HPV-infected head and neck cancer J Pathol 213 2007 283 293
58. I. Martinez, J. Wang, K.F. Hobson, R.L. Ferris, and S.A. Khan Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas Eur J Cancer 43 2007 415 432
59. B.J. Braakhuis, R.H. Brakenhoff, and C.R. Leemans Gene expression profiling in head and neck squamous cell carcinoma Curr Opin Otolaryngology Head Neck Surgery 18 2010 67 71
60. R.J. Slebos, N. Jehmlich, B. Brown, Z. Yin, C.H. Chung, and W.G. Yarbrough et al. Proteomic analysis of oropharyngeal carcinomas reveals novel HPV-associated biological pathways Int J Cancer J Int du Cancer 132 2013 568 579
61. M. Nicolas, A. Wolfer, K. Raj, J.A. Kummer, P. Mill, and M. van Noort et al. Notch1 functions as a tumor suppressor in mouse skin Nat Genet 33 2003 416 421
62. A. Klinakis, C. Lobry, O. Abdel-Wahab, P. Oh, H. Haeno, and S. Buonamici et al. A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia Nature 473 2011 230 233
63. N.J. Wang, Z. Sanborn, K.L. Arnett, L.J. Bayston, W. Liao, and C.M. Proby et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma Proc Nat Acad Sci USA 108 2011 17761 17766
64. S.D. Hayward, J. Liu, and M. Fujimuro Notch, Wnt signaling: mimicry and manipulation by gamma herpesviruses Sci STKE: Signal Transduction Knowledge Environ 2006 2006 re4
65. K.M. Cadigan, and R. Nusse Wnt signaling: a common theme in animal development Genes Dev 11 1997 3286 3305
66. P. Polakis Wnt signaling and cancer Genes Dev 14 2000 1837 1851
67. T.C. He, A.B. Sparks, C. Rago, H. Hermeking, L. Zawel, and L.T. da Costa et al. Identification of c-MYC as a target of the APC pathway Science 281 1998 1509 1512
68. O. Tetsu, and F. McCormick Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells Nature 398 1999 422 426
69. A. Shinohara, Y. Yokoyama, X. Wan, Y. Takahashi, Y. Mori, and T. Takami et al. Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix Gynecol Oncol 82 2001 450 455
70. A. Uren, S. Fallen, H. Yuan, A. Usubutun, T. Kucukali, and R. Schlegel et al. Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression Cancer Res 65 2005 6199 6206
71. C. Perez-Plasencia, G. Vazquez-Ortiz, R. Lopez-Romero, P. Pina-Sanchez, J. Moreno, and M. Salcedo Genome wide expression analysis in HPV16 cervical cancer: identification of altered metabolic pathways Infectious Agents Cancer 2 2007 16
72. T. Rampias, E. Boutati, E. Pectasides, C. Sasaki, P. Kountourakis, and P. Weinberger et al. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells Mol Cancer Res: MCR 8 2010 433 443
73. S.J. Smeets, M. van der Plas, T.B. Schaaij-Visser, E.A. van Veen, J. van Meerloo, and B.J. Braakhuis et al. Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways Int J Cancer J Int du Cancer 128 2011 1596 1605
74. T. Rampias, E. Pectasides, M. Prasad, C. Sasaki, P. Gouveris, and A. Dimou et al. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype Annals Oncol: Official J Eur Soc Med Oncol/ESMO 2013
75. J. Bonilla-Delgado, G. Bulut, X. Liu, E.M. Cortes-Malagon, R. Schlegel, and C. Flores-Maldonado et al. The E6 oncoprotein from HPV16 enhances the canonical Wnt/beta-catenin pathway in skin epidermis in vivo Mol Cancer Res: MCR 10 2012 250 258
76. G. Bulut, S. Fallen, E.M. Beauchamp, L.E. Drebing, J. Sun, and D.L. Berry et al. Beta-catenin accelerates human papilloma virus type-16 mediated cervical carcinogenesis in transgenic mice PLoS ONE 6 2011 e27243
77. R. Kopan, and M.X. Ilagan The canonical Notch signaling pathway: unfolding the activation mechanism Cell 137 2009 216 233
78. A.M. Egloff, and J.R. Grandis Molecular pathways: context-dependent approaches to Notch targeting as cancer therapy Clin Cancer Res: Official J Am Assoc Cancer Res 18 2012 5188 5195
79. J.M. Meyers, J.M. Spangle, and K. Munger The HPV8 E6 protein interferes with NOTCH activation during keratinocyte differentiation J Virol 2013
80. N. Brimer, C. Lyons, and A.E. Wallberg Vande Pol SB. Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling Oncogene 31 2012 4639 4646
81. M.J. Tan, E.A. White, M.E. Sowa, J.W. Harper, J.C. Aster, and P.M. Howley Cutaneous beta-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling Proc Nat Acad Sci USA 109 2012 E1473 E1480
82. A.S. McElhinny, J.L. Li, and L. Wu Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways Oncogene 27 2008 5138 5147
83. H. Kurosu, T. Maehama, T. Okada, T. Yamamoto, S. Hoshino, and Y. Fukui et al. Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110beta is synergistically activated by the betagamma subunits of G proteins and phosphotyrosyl peptide J Biol Chem 272 1997 24252 24256
84. R. Katso, K. Okkenhaug, K. Ahmadi, S. White, J. Timms, and M.D. Waterfield Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer Annu Rev Cell Dev Biol 17 2001 615 675
85. T.F. Franke, D.R. Kaplan, L.C. Cantley, and A. Toker Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate Science 275 1997 665 668
86. A. Klippel, W.M. Kavanaugh, D. Pot, and L.T. Williams A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain Mol Cell Biol 17 1997 338 344
87. Z. Surviladze, R.T. Sterk, S.A. DeHaro, and M.A. Ozbun Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy J Virol 87 2013 2508 2517
88. M. Marsh, and A. Helenius Virus entry: open sesame Cell 124 2006 729 740
89. C.W. Menges, L.A. Baglia, R. Lapoint, and D.J. McCance Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein Cancer Res 66 2006 5555 5559
90. D. Pim, P. Massimi, S.M. Dilworth, and L. Banks Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A Oncogene 24 2005 7830 7838
91. J.M. Spangle, and K. Munger The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis J Virol 84 2010 9398 9407
92. C.L. Arteaga EGF receptor mutations in lung cancer: from humans to mice and maybe back to humans Cancer Cell 9 2006 421 423
93. Y. Samuels, and K. Ericson Oncogenic PI3K and its role in cancer Curr Opin Oncol 18 2006 77 82
94. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, and S.I. Wang et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947
95. J. Albanell, J. Codony-Servat, F. Rojo, J.M. Del Campo, S. Sauleda, and J. Anido et al. Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments Cancer Res 61 2001 6500 6510
96. C.O. Nathan, N. Amirghahari, F. Abreo, X. Rong, G. Caldito, and M.L. Jones et al. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway Clin Cancer Res: Official J Am Assoc Cancer Res 10 2004 5820 5827
97. K. Kozaki, I. Imoto, A. Pimkhaokham, S. Hasegawa, H. Tsuda, and K. Omura et al. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma Cancer Sci 97 2006 1351 1358
98. Y. Cohen, N. Goldenberg-Cohen, B. Shalmon, T. Shani, S. Oren, and N. Amariglio et al. Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma Oral Oncol 47 2011 946 950
99. V.W. Lui, M.L. Hedberg, H. Li, B.S. Vangara, K. Pendleton, and Y. Zeng et al. Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers Cancer Discovery 2013